Drugs / Fluorine F 18 L-glutamate Derivative BAY94-9392
Fluorine F 18 L-glutamate Derivative BAY94-9392
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03824535 | Feb 2019 → Jul 2021 | pulmonary coin lesion | Andrei Iagaru | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluorine F 18 L-glutamate Derivative BAY94-9392 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03824535 ↗ |
| Modality | Diagnostic / imaging agent | “18F-FSPG positron emission tomography (PET)/computed tomography (CT)” NCT03824535 ↗ |
| Route | Intravenous | “Given IV” NCT03824535 ↗ |